Meditation and Depression Relapse Prevention

Meditation and Depression Relapse Prevention refers to research on mindfulness-based cognitive therapy (MBCT) for preventing depressive relapse.

Summary

MBCT was specifically developed to prevent relapse in individuals with recurrent major depression, integrating mindfulness practice with cognitive behavioral principles.

Key Findings

Meta-analyses demonstrate that MBCT reduces relapse risk by approximately 30–40% compared to usual care in individuals with three or more prior episodes. MBCT performs comparably to maintenance antidepressants. Benefits are most pronounced in those with higher baseline rumination and childhood adversity.

Methodology

RCTs follow participants for 12–24 months post-intervention with relapse (diagnostic criteria) as the primary outcome. The most common comparison is maintenance pharmacotherapy or placebo.

Limitations

Benefits are clearest in recurrent (3+ episodes) depression; evidence is weaker for first-episode or chronic depression. Therapist fidelity varies across sites.

Verification Notes

• Kuyken et al. (2016) individual patient data meta-analysis is definitive.
• NICE guidelines recommend MBCT for recurrent depression.